Journal
IMMUNITY
Volume 31, Issue 3, Pages 425-437Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2009.08.014
Keywords
-
Categories
Funding
- National Institutes of Health [HL-36110]
- American Academy of Allergy, Asthma, and Immunology/Altana
- Joycelyn C. Austen Fund for the Career Development of Women Physician-Scientists
Ask authors/readers for more resources
Activated mast cells, eosinophils, and basophils infiltrate the airways of asthmatics as a result of an overexuberant T helper 2 (Th2) cell immune response that drives the production of IgE, primes mast cells and basophils, and promotes tissue eosinophilia and mast cell hyperplasia. Recent evidence demonstrates that these innate effectors can be activated outside of this classical Th2 cell paradigm and that they have additional roles in promoting the development of innate and adaptive pulmonary inflammation. There is also an appreciation for the role of airway epithelial cells in orchestrating allergic pulmonary inflammation. Emerging data from basic research highlight the involvement of many unique pathways in the inflammation triggered by complex native allergens and microbes at the airway mucosal surface. Here, we review the role of effector cells and airway epithelial cells in augmenting and, at times, bypassing traditional Th2 cell-mediated allergic inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available